跳至主要内容
临床试验/ACTRN12616001096448
ACTRN12616001096448已完成3 期

Effectiveness of ketamine therapy among patients with treatment-resistant depression: a double-blind, randomised, controlled trial

niversity of New South Wales0 个研究点目标入组 183 人开始时间: 2016年8月12日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
183

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Criteria assessed by the research team include:
  • -Major Depressive Disorder (MDD) for at least 3 months.
  • -An inadequate response to at least 2 adequate antidepressants courses. Stable dose of antidepressant medications at least 4 weeks prior to trial entry.
  • -Montgomery Asberg Depression Rating Scale (MADRS) score of at least 20.

排除标准

  • Criteria assessed by the research team to determine suitability include:
  • - Psychotic disorder.
  • - Bipolar disorder.
  • -Medical and neurologic conditions.
  • -Psychiatric disorders other than MDD.
  • -Planned major changes to psychotropic medication.
  • -Planned or probable use of ECT.
  • -Risk of suicide.
  • -Substance use, abuse, dependence.
  • -Recent or planned ketamine treatment.
  • -Medical conditions in which use of ketamine or sedating medications may pose a significant health risk.
  • -Women of childbearing potential not taking reliable contraception.
  • - inability to complete the trial

研究者

相似试验

Ketamine for Adult Depression Study | 临床试验